CoChat

Systematic Review of Available CAR-T Cell Trials around the World

Open access
Barros, Luciana Rodrigues Carvalho, Couto, Samuel Campanelli Freitas, da Silva Santurio, Daniela, Paixão, Emanuelle Arantes, Cardoso, Fernanda, da Silva, Viviane Jennifer, Klinger, Paulo, Ribeiro, Paula do Amaral Costa, Rós, Felipe Augusto, Oliveira, Théo Gremen Mimary, Rego, Eduardo Magalhães, Ramos, Rodrigo Nalio, Rocha, Vanderson · 2022 · Cancers
Cited by 76

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

In this systematic review, we foresee what could be the approved scenario in the next few years for CAR-T cell therapies directed against hematological and solid tumor malignancies. China and the USA are the leading regions in numbers of clinical studies involving CAR-T. Hematological antigens CD19 and BCMA are the most targeted, followed by mesothelin, GPC3, CEA, MUC1, HER2, and EGFR for solid tumors. Most CAR constructs are second-generation, although third and fourth generations are being largely explored. Moreover, the benefit of combining CAR-T treatment with immune checkpoint inhibitors and other drugs is also being assessed. Data regarding product formulation and administration, such as cell phenotype, transfection technique, and cell dosage, are scarce and could not be retrieved. Better tracking of trials’ status and results on the ClinicalTrials.gov database should aid in a more concise and general view of the ongoing clinical trials involving CAR-T cell therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cancers14112667

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 76

Metadata

Authors
Barros, L. R. C., Couto, S. C. F., da Silva Santurio, D., Paixão, E. A., Cardoso, F., da Silva, V. J., Klinger, P., Ribeiro, P. D. A. C., Rós, F. A., Oliveira, T. G. M., Rego, E. M., Ramos, R. N., & Rocha, V.
Venue
Cancers
Publisher
MDPI AG
Published
2022-05-27
Volume
14
Issue
11
Pages
2667
ISSN
2072-6694 (ISSN-L)
OpenAlex
W4281965930
Cited by
76
References
14
FWCI
2.91
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Systematic Review of Available CAR-T Cell Trials around the World. https://app.cochat.ai/papers/10.3390/cancers14112667
The paper
Barros, L. R. C., Couto, S. C. F., da Silva Santurio, D., Paixão, E. A., Cardoso, F., da Silva, V. J., Klinger, P., Ribeiro, P. D. A. C., Rós, F. A., Oliveira, T. G. M., Rego, E. M., Ramos, R. N., & Rocha, V. (2022). Systematic Review of Available CAR-T Cell Trials around the World. Cancers. https://doi.org/10.3390/cancers14112667

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.